Phase I and pharmacokinetic study of imatinib mesylate in patients with advanced malignancies and varying degrees of renal dysfunction: a study by the National Cancer Institute Organ Dysfunction Working Group.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples